Objective To investigate glucose metabolism and insulin secretion in patients with chronic hepatitis B( CHB) of different Child-Pugh grades and liver cirrhosis and their association with inflammatory response. Methods A total of 147 patients with CHB and liver cirrhosis who were admitted to Guangzhou Red Cross Hospital from January 2013 to January 2018 were enrolled,and 65 healthy individuals who underwent physical examination in our hospital during the same period of time were enrolled as control group. The clinical data within 12 hours after admission were collected,including age,sex,body mass index,systolic pressure,diastolic pressure,HBV DNA load,total cholesterol,triglyceride,low-density lipoprotein,high-density lipoprotein,alanine aminotransferase,aspartate aminotransferase,tumor necrosis factor α( TNFα),neutrophil-lymphocyte ratio( NLR),fasting blood glucose,plasma insulin,C-peptide level,homeostasis model assessment of insulin resistance( HOMA-IR),and insulin secretion function. Blood glucose,insulin,and C-peptide were recorded at 2 hours after oral glucose tolerance test( OGTT). The chi-square test was used for comparison of categorical data between two groups; the t-test was used for comparison of continuous data between two groups; the Kruskal-Wallis H test was used for comparison of ranked data between multiple groups and further comparison between two groups. A Pearson correlation analysis was used to investigate correlation.Results Compared with the control group,the patients with CHB and liver cirrhosis had significantly higher TNFα,interleukin-6( IL-6),NLR,insulin,and HOMA-IR( all P < 0. 05) and significantly lower insulin secretion function( P < 0. 05). The 147 patients with CHB and liver cirrhosis were divided into Child-Pugh A,B,and C groups according to Child-Pugh grade,and there were significant differences in TNFα,IL-6,NLR,insulin,HOMA-IR,and insulin secretion function between these three groups( all P < 0. 05). Compared with the control group,the patients with CHB and liver cirrhosis had significantly higher blood glucose,insulin,C-peptide,NLR,TNFα,and IL-6 at 2 hours after OGTT( all P < 0. 05); there were significant differences in blood glucose,insulin,NLR,TNFα,and IL-6 at 2 hours after OGTT between the three groups with different Child-Pugh grades( all P < 0. 05). Child-Pugh score was positively correlated with NLR and blood glucose and insulin at 2 hours after OGTT( r = 0. 678,0. 451,and 0. 644,all P < 0. 001),and NLR was positively correlated with blood glucose and insulin at 2 hours after OGTT( r = 0. 408 and 0. 795,both P < 0. 001). Conclusion There is a certain degree of abnormal glucose metabolism and insulin resistance in CHB patients with liver cirrhosis,and the severities of abnormal glucose metabolism and insulin resistance increase with the increase in liver injury,while inflammation may mediate the association between them.
[1] MAYFIELD J. Diagnosis and classification of diabetes mellitus:New criteria[J]. Am Fam Physician,1998,58(6):1355-1362,1369-1370.
|
[2] CHAO LT,WU CF,SUNG FY,et al. Insulin,glucose and hepatocellular carcinoma risk in male hepatitis B carriers:Results from 17-year follow-up of a population-based cohort[J]. Carcinogenesis,2011,32(6):876-881.
|
[3] LU J,HOU X,TU H,et al. Chronic hepatitis B virus infection status is more prevalent in patients with type 2 diabetes[J]. J Diabetes Investig,2017,8(4):619-625.
|
[4] HUANG ZS,HUANG TS,WU TH,et al. Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus:A ten-year observation[J]. J Gastroenterol Hepatol,2010,25(8):1420-1425.
|
[5] SPRADLING PR,SIMONS B,NARAYANAN M,et al. Incidence of diabetes mellitus in a population-based cohort of persons with chronic hepatitis B virus infection[J]. J Viral Hepat,2013,20(7):510-513.
|
[6] MARTNEZ-ESPARZA M,TRISTN-MANZANO M,RUIZ-ALCARAZ AJ,et al. Inflammatory status in human hepatic cirrhosis[J]. World J Gastroenterol,2015,21(41):11522-11541.
|
[7] ZHAO Z,LIU J,WANG J,et al. Platelet-to-lymphocyte ratio(PLR)and neutrophil-to-lymphocyte ratio(NLR)are associated with chronic hepatitis B virus(HBV)infection[J]. Int Immunopharmacol,2017,51:1-8.
|
[8] HERLITZ-CIFUENTES HS,GARCES PC,FERNANDEZ LI,et al. Effect of systemic inflammation on the function of insulin and glucose metabolism in rheumatoid arthritis[J]. Curr Diabetes Rev,2015,12(2):156-162.
|
[9] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J]. J Clin Hepatol,2011,27(1):Ⅰ-ⅩⅥ.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].临床肝胆病杂志,2011,27(1):Ⅰ-ⅩⅥ.
|
[10] LI X,CHEN ZH,XING YF,et al. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma[J]. Tumour Biol,2015,36(4):2263-2269.
|
[11] LIANG LM,XU HX,ZHENG JS,et al. Value of neutrophillymphocyte ratio in predicting the prognosis of patients with decompensated cirrhosis[J]. J Clin Hepatol,2019,35(4):790-795.(in Chinese)梁利民,徐鹤翔,郑吉顺,等.中性粒细胞与淋巴细胞比值对失代偿期肝硬化患者预后的评估价值[J].临床肝胆病杂志,2019,35(4):790-795.
|
[12] PENG Y,LI Y,HE Y,et al. The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis:A systematic review[J]. Expert Rev Gastroenterol Hepatol,2018,12(5):503-513.
|
[13] TABK AG,KIVIMKI M,BRUNNER EJ,et al. Changes in C-reactive protein levels before type 2 diabetes and cardiovascular death:The Whitehall II study[J]. Eur J Endocrinol,2010,163(1):89-95.
|
[14] LI AL,DAI F,PENG Q. Relationship between neutrophil-lymphocyte ratio,red blood cell volume distribution width and hepatitis B and hepatitis B cirrhosis[J]. Med Inf,2019,32(3):69-73,77.(in Chinese)李安乐,戴夫,彭琼.中性粒细胞与淋巴细胞比值、红细胞体积分布宽度与乙型肝炎及乙型肝炎肝硬化的关系研究[J].医学信息,2019,32(3):69-73,77.
|
[15] LORENZO C,HANLEY AJ,HAFFNER SM. Differential white cell count and incident type 2 diabetes:The Insulin Resistance Atherosclerosis Study[J]. Diabetologia,2014,57(1):83-92.
|
[16] MATULEWICZ N,KARCZEWSKA-KUPCZEWSKA M. Insulin resistance and chronic inflammation[J]. Postepy Hig Med Dosw(Online),2016,70:1245-1258.
|
1. | 于天良. 肝硬化腹水患者血清葡萄糖、血清-腹水白蛋白梯度水平与肝功能分级的关系. 大医生. 2024(04): 103-105 . ![]() | |
2. | 王司琪,郭东强,武志峰. 胰腺影像组学对乙肝肝硬化患者肝源性糖尿病的预测价值. 临床医药实践. 2024(07): 527-534 . ![]() | |
3. | 郑玉廷,冯亚园,栗玉龙,袁波,谢峰. DWI联合SIRI预测肝癌经肝动脉化疗栓塞术后短期疗效的价值. 新疆医科大学学报. 2024(08): 1080-1085 . ![]() | |
4. | 董旭,廖威,许明晓,葛玲玲,陈怡,李成忠. HBV相关慢加急性肝衰竭患者低血糖的危险因素及与临床转归的关系. 肝脏. 2024(09): 1117-1122 . ![]() | |
5. | 杨晓丽. 原发性胆汁性肝硬化患者血脂、载脂蛋白A1、载脂蛋白B水平变化及其临床意义. 中国实用医药. 2024(20): 82-85 . ![]() | |
6. | 王鸣,张辉. 吲哚菁绿荧光融合影像技术引导腹腔镜解剖性肝癌切除术治疗原发性肝癌的临床效果. 中国当代医药. 2024(36): 66-69+74 . ![]() | |
7. | 张欢,刘华柱,黄小梅,张丽丽,马欢. 肝硬化腹水患者血清与腹水中LDH、GLU、SAAG水平与肝功能分级及预后关系. 西部医学. 2023(02): 277-281 . ![]() | |
8. | 许秋桂,林裕锋,黎杨杨,黄幸红. 血清总胆固醇、白蛋白与胆碱酯酶联合检测在肝炎肝硬化患者中的诊断价值. 中国当代医药. 2023(05): 148-151 . ![]() | |
9. | 易爱芬,高明. 不同Child-Pugh分级的慢性乙型肝炎合并肝硬化患者糖代谢和胰岛素分泌情况及与炎症反应相关性研究. 黑龙江医学. 2023(06): 663-665 . ![]() | |
10. | 刘日红. 研究肝功能及Child-Pugh分级与诊断老年肝炎肝硬化的关系. 江西医药. 2023(02): 220-221+224 . ![]() | |
11. | 石翠翠,张洁,黄鹤鸣,桑玉尔,李光明. 肝硬化患者胰岛素抵抗的临床分析. 上海交通大学学报(医学版). 2023(02): 188-193 . ![]() | |
12. | 黄宏春,张海波,孟敏. 柴黄汤联合常规西药治疗肝硬化患者的效果. 中国民康医学. 2023(22): 113-115 . ![]() | |
13. | 张鹭坚,蔡梅真. 肝炎肝硬化患者血清总胆固醇、血清白蛋白与胆碱酯酶水平在肝功能评估中的应用. 吉林医学. 2022(02): 482-484 . ![]() | |
14. | 李芳芳,李娟,余真君. 乙肝相关性肝硬化患者肝功能Child-Pugh分级及相关生化指标与血清中HBV DNA水平的相关性. 中国现代医生. 2022(03): 108-111 . ![]() | |
15. | 赵泽源. 慢性乙肝肝硬化患者发生门静脉血栓的影响因素. 中国民康医学. 2022(07): 8-10 . ![]() | |
16. | 王红霞,张琰,曹海英,韩宇,许红丽,王向丽. 中医延续性辨证施膳管理对乙型肝炎肝硬化失代偿期营养风险状态的影响. 中医研究. 2022(07): 20-25 . ![]() | |
17. | 杨鑫,刘小静,王丽,李洁洁,张佳丽,武珊珊. 低血糖对老年失代偿期肝硬化住院患者短期预后的影响. 老年医学与保健. 2022(03): 627-631 . ![]() | |
18. | 李爽旗,蒙连新,韦素雨,王焬圣,季红运,吴娜. 肝硬化伴与不伴肝源性糖尿病临床表现及预后. 肝脏. 2022(06): 668-671 . ![]() | |
19. | 胡瑞华. FT_3、TSH、FT_4水平变化与乙型肝炎肝硬化患者Child-Pugh分级的关联性及临床意义. 黑龙江医药科学. 2022(04): 114-115+117 . ![]() | |
20. | 郑冠群,陈乐. 老年T2DM并H型高血压患者血浆ET、NO的变化及与血压的关系. 心血管病防治知识. 2022(21): 16-19 . ![]() | |
21. | 郑小静,严红虹,甘彬,邱晓婷,丘婕,黄翠娟,陈秀梅. 肝细胞癌患者低血糖发生率和影响因素研究. 护理学报. 2022(17): 43-46 . ![]() | |
22. | 李爽旗,蒙连新,王焬圣,韦素雨,吴娜,季红运. 肝源性糖尿病患者的生活质量现状及其影响因素. 广西医学. 2022(18): 2185-2187 . ![]() | |
23. | 黎美祥. 慢性乙型肝炎患者肝功能与糖代谢、炎症状态的相关性研究. 江西医药. 2022(09): 1154-1156 . ![]() | |
24. | 胡晗,田彩云,张国远,林世德. 肝源性糖尿病发病机制的最新进展. 临床肝胆病杂志. 2021(02): 429-432 . ![]() | |
25. | 冯秀荣,田华,陈光福,王志陆,祝莉. 肝功能四项指标变化与肝炎肝硬化患者Child-Pugh分级的关联性. 河南医学研究. 2021(15): 2857-2859 . ![]() | |
26. | 翟春梅. 基于营养风险评估行针对性营养干预对肝硬化患者肝功能、免疫功能及营养状况的影响. 当代护士(下旬刊). 2021(10): 60-63 . ![]() | |
27. | 林淑珍,张晓静,张志安,刘志华,齐青松. Fibro Touch参数与慢性乙型病毒性肝炎患者血糖及胰岛素水平的相关性. 海南医学. 2021(23): 3103-3105 . ![]() | |
28. | 魏秋丽. 白细胞介素-8血清水平变化和中性粒细胞或淋巴细胞与乙肝肝硬化患者Child-Pugh分级的关联性及临床意义. 内蒙古医学杂志. 2021(11): 1283-1284+1288 . ![]() | |
29. | 余鸿,谷申森,王理瑛,李晓鹏,吐尔洪江·吐逊. 抗病毒联合蛋白营养支持治疗HBV相关性肝硬化失代偿期的临床效果. 中国医药导报. 2020(26): 104-107 . ![]() |